stars 1 stars 2 stars 3

Our mission is to better assess bleeding risk in leukemia patients. Therefore U-PACT offers diagnostic tools based on platelet function. The company's lead product is a platelet activation test based on flow cytometry, which analyses platelet function in blood samples of thrombocytopenic cancer patients.

U-PACT Questions

The U-PACT annual revenue was $5 million in 2026.

The NAICS codes for U-PACT are [62151, 6215, 62, 621].

The SIC codes for U-PACT are [8071, 80, 807].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users